Tetra Discovery Partners Lands New Funding Round

  • Feed Type
  • Date
    10/16/2014
  • Company Name
    Tetra Discovery Partners
  • Mailing Address
    301 Michigan Street NE Grand Rapids, MI 49503 USA
  • Company Description
    Our research focuses on developing new treatments for depression based on subtype-selective modulation of phosphodiesterase 4B (PDE4B). PDE4 in neurons is responsible for the hydrolysis of cAMP. We and our colleagues recently described the protein structure of a key PDE4 regulatory domain known as UCR2.
  • Website
    http://www.tetradiscovery.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    Undisclosed
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The company intends to use the funds to support additional work aimed at the filing of its first Investigational New Drug (IND) application for cognition drug candidate in 2015.
  • M&A Terms
  • Venture Investor
  • Venture Investor

Trending on Xconomy